HEXB Rabbit Monoclonal Antibody

HEXB Rabbit Monoclonal Antibody

Cat: AMRe86899
Size1:50μL Price1:$188
Size2:100μL Price2:$338
Application:WB, IHC-P

Reactivity:Human
Conjugate:Unconjugated
Optional conjugates: Biotin, FITC (free of charge).
See other 26 conjugates.

Gene Name:HEXB
Category: Recombinant Monoclonal Antibody Tags: , , , ,

Summary

Production Name

HEXB Rabbit Monoclonal Antibody

Description

Rabbit Monoclonal antibody

Host

Rabbit

Application

WB, IHC-P

Reactivity

Human

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Monoclonal Antibody

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% protective protein . Stable for 12 months from date of receipt.

Purification

Affinity Purification

 

Immunogen

Gene Name

HEXB

Alternative Names

ENC-1AS; HEL-248; HEL-S-111

Gene ID

3074

SwissProt ID

P07686

 

Application

Dilution Ratio

WB: 1:1000-1:5000 IHC-P: 1:20-1:200

Molecular Weight

Calculated MW:63 kDa; Observed MW:63 kDa

 

Background

Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]

 

Research Area

Other glycan degradation;Amino sugar and nucleotide sugar metabolism;Glycosaminoglycan degradation;Glycosphingolipid biosynthesis;Glycosphingolipid biosynthesis;Lysosome;